Komori
Takara Bio (4974) · InitiativeFirst stated

Exclusive Development and Commercial Partnership with Dong-A ST for C-REV in South Korea

First written in FY2019. . Latest entry: FY2019.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
C-REV’s Exclusive Development and Sales Partnership with Dong-A ST in KoreaA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2019First statedAnnual report

    「In August 2018, the Company entered into a license agreement with Dong-A ST Co., Ltd. granting exclusive rights to develop and commercialize C-REV in South Korea. The Company will continue to pursue new partnerships overseas.」

    First disclosed an overseas license agreement granting exclusive development and commercialization rights for C-REV in South Korea.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Takara Bio yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Exclusive Development and Commercial Partnership with Dong-A ST for C-REV in South Korea | TAKARA BIO INC. (4974) | Komori